Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination of ISM2196, an AI-driven, potential best-in ...
Check if you have access via personal or institutional login Practical Techniques in Molecular Biotechnology intends to familiarise students with the basics of the well-known experiments of molecular ...
The Centre unveiled its BioE3 (Biotechnology for Economy, Environment and Employment) policy last week. On the face of it, the policy appears to be a routine attempt to create incentives and ...
The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...
Recursion reported mixed data Tuesday from its first Phase 2 study, in a disappointing start to an expected frenzy of clinical results.
WHEN the Covid-19 pandemic broke out, countries scrambled for a way to quickly detect the disease. This brought public attention to the field of genomics – a branch of molecular biology concerned with ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...
These companies are nearly in the sweet spot of risk versus reward in biotech. Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a ...
Ginkgo Bioworks seeks to create a high-throughput biopharma services platform. So far, that platform isn't profitable, but it can still generate a lot of scientific data. Selling the totality of ...
Now, let's turn our attention to the biotech stocks that are anticipating FDA decisions in September. Travere Therapeutics Inc. (TVTX) The FDA is scheduled to determine whether or not to convert ...
Zydus Lifesciences Ltd announced today that its wholly-owned subsidiary, Zydus Animal Health and Investments Ltd, has completed the acquisition of a 50 per cent equity stake in Sterling Biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback